Related references
Note: Only part of the references are listed.Adjuvant Chemotherapy for Stage II Colon Cancer With Poor Prognostic Features
Erin S. O'Connor et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Mortality by Stage for Right- Versus Left-Sided Colon Cancer: Analysis of Surveillance, Epidemiology, and End Results-Medicare Data
Jennifer M. Weiss et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Long-Term Survival Results of Surgery Alone Versus Surgery Plus 5-Fluorouracil and Leucovorin for Stage II and Stage III Colon Cancer: Pooled Analysis of NSABP C-01 Through C-05. A Baseline from Which to Compare Modern Adjuvant Trials
Neal W. Wilkinson et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Comparison of 17,641 Patients With Right- and Left-Sided Colon Cancer: Differences in Epidemiology, Perioperative Course, Histology, and Survival
Frank Benedix et al.
DISEASES OF THE COLON & RECTUM (2010)
Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials
Daniel Sargent et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
Thierry Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Trends in colorectal cancer testing among medicare subpopulations
Joshua J. Fenton et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2008)
Is there a difference in survival between right- versus left-sided colon cancers?
Robert A. Meguid et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Adjuvant chemotherapy after resection in elderly Medicare and Medicaid patients with colon cancer
Cathy J. Bradley et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Molecular Characterization of MSI-H Colorectal Cancer by MLH1 Promoter Methylation, Immunohistochemistry, and Mismatch Repair Germline Mutation Screening
Jenny N. Poynter et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
FOLFOX and FLOX Regimens for the Adjuvant Treatment of Resected Stage II and III Colon Cancer
Saima Sharif et al.
CANCER INVESTIGATION (2008)
Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer
Alberto Malesci et al.
CLINICAL CANCER RESEARCH (2007)
The design versus the analysis of observational studies for causal effects:: Parallels with the design of randomized trials
Donald B. Rubin
STATISTICS IN MEDICINE (2007)
Reoperation as a quality indicator in colorectal surgery - A population-based analysis
Arden M. Morris et al.
ANNALS OF SURGERY (2007)
Completion of therapy by medicare patients with stage III colon cancer
Sharon A. Dobie et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid
K Birkenkamp-Demtroder et al.
GUT (2005)
Systematic review of microsatellite instability and colorectal cancer prognosis
S Popat et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer
AB Benson et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Adjuvant therapy for stage II colon cancer: A systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group
A Figueredo et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Two colons-two cancers: Paradigm shift and clinical implications
P Gervaz et al.
JOURNAL OF SURGICAL ONCOLOGY (2004)
Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer:: Who benefits and by how much?
S Gill et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
CM Ribic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Are there two sides to colorectal cancer?
B Iacopetta
INTERNATIONAL JOURNAL OF CANCER (2002)
Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer
D Schrag et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy
A Hemminki et al.
GASTROENTEROLOGY (2000)
The role of the propensity score in estimating dose-response functions
GW Imbens
BIOMETRIKA (2000)
Share Paper
